Literature DB >> 20180928

Pandemic influenza A/H1N1 and organ donation.

R Lattes1, N Jacob, J de la Fuente, G Fragale, P Massari.   

Abstract

One of the concerns regarding the pandemic of novel influenza A/H1N1 virus is its potential to hamper transplant programs if the decision is made that organs from donors with influenza A/H1N1 should not be used. Evidence of transmissibility through organ transplantation is speculative at best. We report the outcome of 2 kidney transplant recipients who received kidneys from the same deceased donor, in whom the diagnosis of infection by the novel virus became available only after engraftment. The donor also had received a complete course of antiviral treatment before donation. The recipients were transplanted at 2 different facilities and were managed differently. Neither recipient developed flu syndrome, and both had an uneventful outcome. It is possible to speculate that kidneys from donors who have had confirmed influenza A/H1N1 and who have received antiviral treatment can be safely used in transplantation.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20180928     DOI: 10.1111/j.1399-3062.2010.00494.x

Source DB:  PubMed          Journal:  Transpl Infect Dis        ISSN: 1398-2273            Impact factor:   2.228


  1 in total

1.  Kidney transplantation from a SARS-CoV-2-positive donor for the recipients with immunity after COVID-19.

Authors:  Lina Puodziukaite; Mindaugas Serpytis; Aurelija Kundrotaite; Jurate Sipylaite; Marius Miglinas; Marta Monika Janusaite; Egle Asakiene; Erika Milisauskaite; Arunas Zelvys; Oleg Aliancevic; Ligita Jancoriene
Journal:  Transpl Infect Dis       Date:  2021-06-22
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.